Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report.

نویسندگان

  • Ziqiang Wu
  • Jingjing Huang
  • Srinivas Sadda
چکیده

INTRODUCTION This study reports a case of bevacizumab administered to treat choroidal neovascularisation in a woman later discovered to be pregnant. CLINICAL PICTURE A 25-year-old pregnant woman developed myopic choroidal neovascularisation in both eyes. TREATMENT Both eyes were treated with a total of 3 intravitreal injections of bevacizumab sequentially. OUTCOME Vision improved significantly in both eyes. There were no evident pregnancy-related complications at 1 year postpartum. CONCLUSION Although anti-vascular endothelial growth factor (VEGF) therapy did not result in any detectable short-term adverse event in this mother and baby, the potential toxicity of these agents must be carefully considered in pregnant patients.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intravitreal injection of bevacizumab for the treatment of choroidal neovascularization in a patient with angioid streaks.

We report the favorable outcome of intravitreal injection of bevacizumab (Avastin) to treat choroidal neovascularisation (CNV) secondary to angioid streaks in an 82-year-old Chinese man. Within 2 weeks of bevacizumab injection, visual acuity improved from 20/40 to 20/25 and optical coherence tomography revealed complete resolution of CNV and retinal edema. The juxtafoveal hemorrhage nearly disa...

متن کامل

[Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture].

CASE REPORT A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C(3)F(8) and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) ...

متن کامل

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

Bevacizumab (Avastin, Genentech) is a recombinant humanised, full length, antiVEGF monoclonal antibody that binds all isoforms of VEGF-A. It has been shown to prolong survival of patients with advanced colon cancer when combined with 5-fluorouracil. In this report, we describe the effect of bevacizumab in two patients with choroidal neovascularisation (CNV) secondary to pathological myopia, whi...

متن کامل

Microstructural Effects of Intravitreal Bevacizumab in Idiopathic Choroidal Neovascularisation.

BACKGROUND Idiopathic choroidal neovascularization (ICNV) is a unilateral ocular disease which occurs in patients younger than 50 years and accounts for approximately 17% of patients with CNV. We evaluated microstructural effects of intravitreal bevacizumab in eyes with treatment-naïve idiopathic choroidal neovascularisation. METHODS In this case series study we reviewed the treatment and fol...

متن کامل

Peripapillary Neovascular Membrane in a Young Pregnant Woman and Prompt Response to Ranibizumab Injections following Uneventful Delivery

PURPOSE Occurrence of choroidal neovascularization (CNV) during pregnancy has been reported as a complication of presumed ocular histoplasmosis syndrome or punctuate inner chorioretinopathy. To our knowledge, idiopathic CNV (ICNV) during pregnancy has only been reported once in the relevant literature. Bevacizumab has been used for the treatment of ICNV in small case series. However, there is l...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Annals of the Academy of Medicine, Singapore

دوره 39 2  شماره 

صفحات  -

تاریخ انتشار 2010